TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors

EMBO Journal

Volumn 15, Issue 14, 1996, Pages 3667-3675

  Voegel, Johannes J ^a   Heine, Matthias J S ^a   Zechel, Christina ^a   Chambon, Pierre ^a   Gronemeyer, Hinrich ^a  

^a PSL Research University   (France)

Author keywords

Ligand binding domain; Retinoid receptors; Steroid receptors; Transcriptional coactivator; Transcriptional squelching

Indexed keywords

CELL NUCLEUS RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ISOLATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 0029954339     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00736.x     Document Type: Article

References (41)

1. Ausubel, F.M., Brent, R., Kingston, R., Moore, D., Seidman, J.J., Smith, J. and Struhl, K. (1993) Current Protocols in Molecular Biology. John Wiley & Sons, New York.
2. Barettino, D., Vivanco-Ruiz, M.D.M. and Stunnenberg, H.G. (1994) Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J., 13, 3039-3049.
3. Beato, M., Herrlich, P. and Schütz, G. (1995) Steroid hormone receptors: many actors in search of a plot. Cell, 83, 851-857.
4. Berry, M., Metzger, D. and Chambon, P. (1990) Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen hydroxytamoxifen. EMBO J., 9, 2811-2819.
5. Bocquel, M.T., Kumar, V., Stricker, C., Chambon, P. and Gronemeyer, H. (1989) The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor- and cell-specific. Nucleic Acids Res., 17, 2581-2595.
6. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. and Moras, D. (1995) Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature, 375, 377-382.
7. Cavaillès, V., Dauvois, S., Daniellian, P.S. and Parker, M.G. (1994) Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl Acad. Sci. USA, 91, 10009-10013.
8. Cavaillès, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P.J. and Parker, M.G. (1995) Nuclear factor RIPI40 modulates transcriptional activation by the estrogen receptor. EMBO J., 14, 3741-3751.
9. Chen, J.Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J.E., Reczek, P., Chambon, P. and Gronemeyer, H. (1995) RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J., 14, 1187-1197.
10. Chen, Z.P., Shemshedini, L., Durand, B., Noy, N., Chambon, P. and Gronemeyer, H. (1994) Pure and functionally homogeneous recombinant retinoid X receptor. J. Biol. Chem., 269, 25770-25776.
11. Danielian, P.S., White, R., Lees, J.A. and Parker, M.G. (1992) Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J., 11, 1025-1033.
12. Durand, B., Saunders, M., Gaudon, C., Roy, B., Losson, R. and Chambon, P. (1994) Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J., 13, 5370-5382.
13. Gronemeyer, H. and Laudet, V. (1995) Transcription factors 3: nuclear receptors. Protein Profile, 2, 1173-1380.
14. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C. and Brown, M. (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science, 264, 1455-1458.
15. II30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell, 79, 107-117.
16. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M.P., Durand, B., Lanotte, M., Berger, R. and Chambon, P. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J., 11, 629-642.
17. Kastner, P., Mark, M. and Chambon, P. (1995) Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell, 83, 859-869.
18. Kurokawa, R., Söderström, M., Hörlein, A., Halachmi, S., Brown, M., Rosenfeld, M.G. and Glass, C.K. (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature, 377, 451-454.
19. Le Douarin, B., Zechel, C., Garnier, J.M., Lutz, Y., Tora, L., Pierrat, B., Heery, D., Gronemeyer, H., Chambon, P. and Losson, R. (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J., 14, 2020-2033.
20. Lee, J.W., Choi, H.S., Gyurist, J., Brent, R. and Moore, D.D. (1995a) Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol., 9, 243-254.
21. Lee, J.W., Ryan, F., Swaffield, J.C., Johnston, S.A. and Moore, D.D. (1995b) Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature. 374, 91-94.
22. Leng, X., Blanco, J., Tsai, S.Y., Ozato, K., O'Malley, B.W. and Tsai, M.-J. (1995) Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. Cell. Biol., 15, 255-263.
23. Mangelsdorf, D.J. and Evans, R.M. (1995) The RXR heterodimers and orphan receptors. Cell, 83, 841-850.
24. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. and Evans, R.M. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
25. II28: three subunits of the human transcription factor TFIID. EMBO J., 14, 1520-1531.
26. Meyer, M.E., Gronemeyer, H., Turcotte, B., Bocquel, M.T., Tasset, D. and Chambon, P. (1989) Steroid hormone receptors compete for factors that mediate their enhancer function. Cell, 57, 433-442.
27. Meyer, M.E., Pornon, A., Ji, J.J., Bocquel, M.T., Chambon, P. and Gronemeyer, H. (1990) Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J., 9, 3923-3932.
28. Nagpal, S., Saunders, M., Kastner, P., Durand, B., Nakshatri, H. and Chambon, P. (1992) Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell, 70, 1007-1019.
29. Nagpal, S., Friant, S., Nakshatri, H. and Chambon, P. (1993) RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J., 12, 2349-2360.
30. Onate, S.A., Tsai, S.Y., Tsai, M.J. and O'Malley, B. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science, 270, 1354-1357.
31. Renaud, J.P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H. and Moras, D. (1995) Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature, 378, 681-689.
32. Seipel, K., Georgiev, O. and Schaffner, W. (1992) Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J., 11, 4961-4968.
33. Strähle, U., Schmid, W. and Schütz, G. (1988) Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J., 7, 3389-3395.
34. Tasset, D., Tora, L., Fromental, C., Scheer, E. and Chambon, P. (1990) Distinct classes of transcriptional activating domains function by different mechanisms. Cell, 62, 1177-1187.
35. Thummel, C.S. (1995) From embryogenesis to metamorphosis: the regulation and function of Drosophila nuclear receptor superfamily members. Cell, 83, 871-877.
36. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E. and Chambon, P. (1989) The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell, 59, 477-487.
37. vom Baur, E., Zechel, C., Heery, D., Heine, M.J.S., Garnier, J.M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P. and Losson, R. (1996) Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J., 15, 110-124.
38. Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D. and Fletterick, R.J. (1995) A structural role for hormone in the thyroid hormone receptor. Nature, 378, 690-697.
39. Webster, N.J., Green, S., Jin, J.R. and Chambon, P. (1988) The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell, 54, 199-207.
40. Wurtz, J.M., Bourguet, W., Renaud, J.P., Vivat, V., Chambon, P., Moras, D. and Gronemeyer, H. (1996) A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol., 3, 87-94.
41. Zenke, M., Munoz, A., Sap, J., Vennström, B. and Beug, H. (1990) v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell, 61, 1035-1049.